Jin Wang
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Epidemiology top 1%
- Adipokines, Inflammation, and Metabolic Diseases
- Liver Disease Diagnosis and Treatment
Papers in
-
- Circular RNAs in diseases 28
- RNA modifications and cancer 22
- Cancer-related gene regulation 10
-
- Cancer-related molecular mechanisms research 29
- MicroRNA in disease regulation 29
- Co-authors
- Subrata Sen (11 shared papers)Tsu‐Shuen Tsao (1 shared paper)Harvey F. Lodish (1 shared paper)Christopher Hug (1 shared paper)Jonathan S. Bogan (1 shared paper)Zuojia Liu (7 shared papers)Frederick P. Rivara (15 shared papers)Xunzhe Yin (5 shared papers)
- Journals
- Journal of Translational Medicine (7 papers)Scientific Reports (6 papers)Journal of Clinical Oncology (5 papers)Frontiers in Oncology (5 papers)Mathematical Biosciences & Engineering (5 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jin Wang
331 papers receiving 9.8k citations
Jin Wang's Hit Papers
Peers
Comparison fields: 5 of 177
- Cancer Research 2.5k
- Epidemiology 2.0k
- Molecular Biology 3.9k
- Oncology 1.3k
- Modeling and Simulation 163
Countries citing papers authored by Jin Wang
This map shows the geographic impact of Jin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Wang more than expected).
Fields of papers citing papers by Jin Wang
This network shows the impact of papers produced by Jin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Wang. The network helps show where Jin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 354 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin Hit paper breakdown → | 2004 | 715 |
| 2 | MicroRNA as Biomarkers and Diagnostics Hit paper breakdown → | 2015 | 632 |
| 3 | 2009 | 492 | |
| 4 | Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment Hit paper breakdown → | 2022 | 244 |
| 5 | 2018 | 218 | |
| 6 | 2005 | 198 | |
| 7 | Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis Hit paper breakdown → | 2022 | 192 |
| 8 | 2019 | 167 | |
| 9 | 2009 | 147 | |
| 10 | 2010 | 140 | |
| 11 | 2014 | 133 | |
| 12 | 2022 | 126 | |
| 13 | 2009 | 123 | |
| 14 | 2013 | 120 | |
| 15 | 2018 | 115 | |
| 16 | 2020 | 112 | |
| 17 | 2014 | 106 | |
| 18 | 2004 | 99 | |
| 19 | 2022 | 97 | |
| 20 | 2015 | 97 |
About Jin Wang
Jin Wang is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 354 papers that have together received 10.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (29 papers), MicroRNA in disease regulation (29 papers), Circular RNAs in diseases (28 papers), RNA modifications and cancer (22 papers), COVID-19 epidemiological studies (19 papers), Liver Disease Diagnosis and Treatment (13 papers), Cancer-related gene regulation (10 papers) and SARS-CoV-2 and COVID-19 Research (10 papers). The work is most often cited by research in Cancer Research (2.5k citations), Epidemiology (2.0k citations), Molecular Biology (3.9k citations), Oncology (1.3k citations) and Modeling and Simulation (163 citations). Jin Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Subrata Sen, Tsu‐Shuen Tsao, Harvey F. Lodish, Christopher Hug, Jonathan S. Bogan, Zuojia Liu, Frederick P. Rivara, Xunzhe Yin, Xiangyu Guo and Jinyun Chen. Their work appears in journals such as Journal of Translational Medicine, Scientific Reports, Journal of Clinical Oncology, Frontiers in Oncology and Mathematical Biosciences & Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.